multi topic faculty meeting april 25 2014 school of
play

Multi - Topic Faculty Meeting April 25, 2014 School of Pharmacy - PowerPoint PPT Presentation

Multi - Topic Faculty Meeting April 25, 2014 School of Pharmacy Graduate Program Admissions and Update Maggie Folan Applicants for 2014 Admission 100 90 Number of Applicants 80 INTERNATIONAL DOMESTIC 70 60 50 40 30 20 10 0


  1. “Multi - Topic” Faculty Meeting April 25, 2014 School of Pharmacy

  2. Graduate Program Admissions and Update Maggie Folan

  3. Applicants for 2014 Admission 100 90 Number of Applicants 80 INTERNATIONAL DOMESTIC 70 60 50 40 30 20 10 0 NTMS NTMS After MS Before MS After PhD Before PhD After Before Criteria Criteria Criteria Criteria Criteria Criteria Criteria = Minimum TOEFL of 94

  4. 2013 vs 2014 Applications 160 140 Number of Applicants INTERNATIONAL DOMESTIC 120 100 80 60 40 20 0 NTMS 2013 NTMS 2014 MS 2013 MS 2014 PhD 2013 PhD 2014 Criteria = Minimum TOEFL of 94

  5. 2014 Admissions 30 NTMS MS PhD Number of Applicants 25 5 20 7 4 15 6 10 1 8 5 4 0 Offers Accepts Declines Response

  6. • Percent Accepted = 25% (26/102) • Yield = 65% (#deposits/#offers) • Number of Students projected to matriculate in 2014 • 10 NTMS • 6 MS • 4 PhD

  7. Currently Enrolled Students 60 Of a total of 80 Number of Applicants 50 full-time students 37 are 40 paying own 30 20 10 0 NTMS (19) NTMS MS (10) MS paying PhD (53) PhD paying Paying own own own tuition Tuition Tuition (10) Full-time Part-time

  8. Projections for FY ’ 15 Enrollment 60 Number of Students 50 Full-time Part-time 40 30 20 10 0 NTMS MS (16) PhD (55) (13)

  9. PharmD Admissions Sharon Connor

  10. Admissions Committee • Fran Balog • Bobbie Farrah • Marcia Borelli • Maggie Folan • Sharon Connor • Bob Gibbs • Jim Coons • Irene Gathuru • Sharon Corey • Mike Mokotoff • Colleen Culley • Brian Potoski • Tanya Fabian • Carolyn Thorpe

  11. Total Applications Class of Class of 2017 2018 Number of Applicants 598 597 Number of Completed 400 394 Supplemental Applications Number Interviewed - Open 155 157 Conditional Acceptances 45 43 Offers Made 154 143 Deposits 126 (82%) 119 (83%) Declined After Deposit 13 4 Final Yield 73% 80%

  12. Class of Class of 2017 2018 Total 113 115 (deposited) 45 (40%) 43 (37%) - Conditional 73 (61%) 72 (63%) - Open # Female 72 (64%) 79 (69%) # Minorities 6 (5%) 6 (5%) # from PA 80 (67%) 83 (72%) # with Degrees 23 (20%) 31 (27%) Average GPA 3.6 3.6 Average Science GPA 3.4 3.4 Average PCAT 82% 81%

  13. Outside Institutions Class of 2017 Class of 2018 Allegheny Penn State Bethany College SUNY College Point Park Bucknell Temple Case Western St. Francis Case Western University of Reserve Reserve U Chicago SUNY-Binghamton Florida State UC – Riverside CUNY U. of Akron Goucher Connecticut College UCLA UC-SD College Harvard UCSD UC-Irvine Hofstra Kent State U of Arizona U. of Cincinnati Mount Aloysius Marymount U U of Michigan U. of Florida Mount Holyoke Montgomery College University of Utah U. of Maryland Niagra Ohio State Wayne State Ursinus College Ohio State Penn State Wilkes Richard Stockton College of New Jersey

  14. Residency Update Heather Johnson

  15. Results – Student Seeking Residencies Registered for Match: 39 1 job 1 fellowship Submitted Ranks: 35 1 fellowship 4 Looking 1 residency 29 Matched 8 Pitt/UPMC 21 Elsewhere 1 Resident 1 AGH

  16. PharmD Respondents ‐ 20 • Applications – 1 ‐ 13 (9) • Interviews – 1 ‐ 11 (5.5) – 70% • Rank – 1 ‐ 4 (median – 1)

  17. Results – Residency Programs 2014 ‐ 15Residents: 44 Positions Matched: 41 Positions Filled: 44 30 PGY1 14 PGY2 4 Pitt 9 Pitt 6 UPMC

  18. Matched Candidates 14 12 10 8 6 4 2 0 applications interviews Fraction Int rank First line: Maximum #; Second line: Minimum #; Third line: Average #; Remaining lines: Individual applicants

  19. Phil Empey Pharmacogenomics

  20. Pharmacogenomics-guided Care to Improve the Safety and Effectiveness of Medications (PreCISE-Rx)

  21. Objective: To predict of individual patient phenotypes by integrating genomics and clinical variables to improve medication outcomes of the population. Approach: Phased, standard of care implementation using panel based genotyping to lay scalable foundation for broad clinical impact and research ROI. Pilot hypothesis: Pharmacogenomics-guided therapy individualization is clinically feasible at Pitt/UPMC; specifically, that CYP2C19 variants are detectable in our patients and that point-of-care interventions can be accomplished

  22. Stakeholder team: and clinical stakeholders, IRB, DBMI, PMTF, PMTT, medical genetics, pathology Resource commitments: IPM, CTSI, grants, donors Progress update on components: – Clinical – Informatics – Testing – IRB/Research – Education – Registry/Bio-banking

  23. PreCISE-Rx: Pitt/UPMC implementation framework EMR (Cerner/Epic) Test development Testing Lab routine Sample CLIA Pre-emptive validation/ Order PGx Panel update Platform Indication-based P Drug Policy / Knowledgebase A Genetic data - Clinical implementation team T (P&T, clinical stakeholders) - Local drug use policy development clinical variables Actionable non-actionable CLINICAL H (order sets/pathways) Pending W - Automated genotype-phenotype Decision support results interpretation/text A - Literature knowledgebase Quality Y Released - Education (provider/patients) Review structured notes results - Reporting program (metrics, S Genetic Data - Star alleles analytics, and surveillance) - diplotypes Storage and diplotype Drug therapy Outcome PGx assignment Patient Education Portal resource Drug response phenotyping - structured notes - additional data collection - adherence assessment Enterprise data warehouse - ROI/cost RESEARCH Consent DB/Registry 1. Future clinical use (of currently non-actionable results) Bio Enterprise data warehouse 2. EMR linked data for research bank 3. Sample bio-banking 4. Re-contact V3.3, 3/18/14

  24. Noteworthy Student International Work • 29 students, 30 international rotations • 4 P3 students to Shanghai in May (Xie, Smith) • 5 student global travel scholarships (Connor, Jonkman) + 2 with special funding from the Center for Global Health • 1 Howard Hughes K-RITH research fellowship • 3 IPSF student exchange program participants

  25. Pitt Pharmacy Around the Globe Dublin London Palestine Shanghai Palermo Honduras Philippine s Malawi Australia Durban

  26. P4 International Rotations 35 30 30 Other 25 Philippines China 20 17 Malawi 15 13 London 10 8 7 7 Australia 5 Dublin Palermo 0 Honduras

  27. International Policies • New course fee ($500) – International rotation – must register as such with Anna Stracci – Mentored international summer experience – must register for IPSE (International Pharmacy Scholarly Experiences) • Students must register with study abroad office for any school-related experience • Faculty should register with the travel registry

  28. “Multi - Topic” Faculty Meeting April 25, 2014 School of Pharmacy

  29. The University of Pittsburgh is:  Aggressively pursuing excellence in undergraduate education  Building on national prominence in research  Ensuring cost-effectiveness and efficiency  Securing an adequate resource base  Partnering in community development Abstracted from the Update: Pitt in the Year 2000: Pursuing Our Full Potential

  30. Statement of Aspiration and Strategic Priorities February 28, 2014 • Consistently Deliver Excellence in Education • Make Contributions of Impact through Pioneering Research • Build Community Strength • Extend Our Global Reach • Provide Top Value • Secure an Adequate Resource Base

  31. Student Experience in the Research University

  32. Salk Pavilion Photos Construction Progress Patricia Kroboth

  33. Coffee Shop

  34. Hallway to Conference Room Hallway View #1

  35. Hallway Looking at Break Area Hallway View #2

  36. Office Office View #1

  37. Office Office View #2

  38. Conference Room Conference Room View #1

  39. Conference Room Conference Room View #2

  40. Open Lab Open Lab View #1

  41. Open Lab Open Lab View #2

  42. Cold Room

  43. Procedure Room

  44. Break Area

  45. Bridge Looking at Salk Hall View #1

  46. View of the Commons from Bridge Bridge View #2

  47. Bridge Looking At Salk Pavilion Bridge View #3

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend